[Noninvasive respiratory support in coronavirus disease 2019 patients: excess is as wrong as insufficiency]

C Pan; W Zhang; J A Xia; H Liu; B Du; H B Qiu

doi:10.3760/cma.j.cn112138-20200219-00099

[Noninvasive respiratory support in coronavirus disease 2019 patients: excess is as wrong as insufficiency]

Zhonghua Nei Ke Za Zhi. 2020 Sep 1;59(9):666-670. doi: 10.3760/cma.j.cn112138-20200219-00099.

[Article in Chinese]

Authors

C Pan¹, W Zhang², J A Xia³, H Liu⁴, B Du⁵, H B Qiu¹

Affiliations

¹ Department of Critical Care Medicine, Zhongda Hospital, Southeast University, Nanjing 210009, China.
² Department of Emergency,the 900th Hospital of Joint Service Corps of Chinese PLA, Fuzhou 350025, China.
³ Department of Critical Care Medicine, Wuhan Jinyintan Hospital, Wuhan 430013, China.
⁴ Department of Critical Care Medicine, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
⁵ Department of Medical Intensive Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.

PMID: 32838497
DOI: 10.3760/cma.j.cn112138-20200219-00099

Abstract

新型冠状病毒易导致急性呼吸窘迫综合征（ARDS），已对生命安全构成极大威胁。无创呼吸辅助治疗是新型冠状病毒肺炎引起ARDS的常规治疗手段，但在治疗过程中，往往存在过度使用无创呼吸功能支持治疗而导致气管插管延迟，进而影响患者的预后。因此，了解无创通气使用指征和禁忌，早期识别无创通气治疗失败的危险因素，适时终止无创通气转为有创通气是目前临床医师亟需关注的问题。.

MeSH terms

Betacoronavirus*
COVID-19
Coronavirus Infections*
Humans
Pandemics*
Pneumonia, Viral*
Respiratory Insufficiency
SARS-CoV-2